A Houston company has announced a new service that will encourage electric vehicle use. Photo via Getty Images

Houston-based energy retailer Octopus Energy U.S. is now getting its tentacles into the electric vehicle business.

Octopus Energy US on July 6 unveiled Octopus Electric Vehicles, whose first offering is EV Concierge. This new service will help customers lease an EV, and integrate smart charging and billing into their existing energy plan.

New and existing customers in Texas can apply for the beta leasing program at octoev.us. Employees of the program will help customers search for a new or used EV to lease, install an at-home EV charger, and adopt best practices for EV ownership.

“Interest in electric vehicles is at an all-time high. With Texas as the third-largest market for EVs and a global leader in energy, we will be positioned to help customers realize vehicle and energy savings all on one bill,” says Chris George, U.S. director of Octopus Electric Vehicles. “As fossil fuel continues to be impacted by inflation, it’s never made more sense to get an EV paired with smart charging to extract the lowest-priced energy from the grid.”

EV Concierge is paired with Intelligent Octopus, which lets customers access power when it is cheaper and greener while helping balance stability of power grid.

Octopus Electric Vehicles launched in 2018 in the United Kingdom, where parent company Octopus Energy Group is based. In the U.K., Octopus leases EVs, installs at-home chargers, provides EV tax breaks, and provides access to more than 250,000 public charging stations in Europe.

Customers of Octopus Electric Vehicles can lease 65 different EVs from 28 automotive brands.

“We’ve seen that consumers are looking for experts that can offer the full EV package to guide them through their journey,” says Fiona Howarth, CEO of Octopus Electric Vehicles. “With more EV models entering the market every month, and innovative tariffs like Intelligent Octopus making charging your car as easy as [charging] your phone, we only expect the transition to accelerate.”

The launch of EV Concierge comes just a year after Octopus Energy U.S. set up shop in Houston. Establishment of the Houston presence coincided with the company’s $5 million acquisition of Houston-based Evolve Energy.

Last month, Kraken Technologies, the software licensing arm of Octopus Energy Group, picked Houston for its U.S. headquarters.

Octopus Energy Group, valued at nearly $5 billion, entered the U.S. market in 2020. It supplies green energy to more than 3 million retail customers around the world.

From the potential for electric vehicle growth to the role of corporates, experts joined a panel to discuss the progress of Houston's low-carbon energy initiatives. Photo by Katya Horner

Overheard: Here's where Houston's low-carbon efforts stand, according to the experts

eavesdropping online

Houston is moving the needle on low-carbon initiatives, as one panel agreed at the Center for Houston's Future's Low-Carbon Energy Innovation Summit.

The annual event, which is taking place virtually this year, was broken up into two days. The first installment focused on low-carbon markets on October 8. This week on October 15, the virtual programming will cover Houston's energy ecosystem.

While the day of low-carbon programming zeroed in on specifics within the subject, one panel zoomed out to check in on Houston's progress. Brett Perlman, president and CEO for the center for Houston's Future, moderated the discussion, which featured five energy experts. Here are some highlights from the panel.

“We’ve identified 200 companies in Houston that we would call energy 2.0 companies — solar, wind, energy stories, and other energy and clean tech companies. So, there’s already a lot happening.”

— Bob Harvey, president and CEO of the Greater Houston Partnership.

“While innovation and the energy transition are not the same thing, they are close cousins. Innovation is about change and new businesses and how they work with incumbent businesses, so when you think about the transition, you have to include both of them.”

— Barbara Burger, Chevron's vice president of innovation and president of Chevron Technology Ventures.

“Hurricane Harvey was a point where so much changed. Everything I do in my job changed. We went from climate being talked about discretely to something we can’t not talk about. It’s in every conversation whether we like it or not.”

— Lara Cottingham, chief of staff and chief sustainability officer for the city of Houston.

“This is a global challenge, but Houston is a global leader. We really want to be hands on and tackle this to keep Houston in that leadership role.”

— Cottingham continues.

“Houston has the engineering expertise and experience doing energy at scale. Frankly, we need that set of expertise at the table.”

— Emily Reichert, CEO of Greentown Labs, which recently expanded to Houston.

“We’d like to see 30 percent of new vehicle sales be electric vehicles by 2030. I think we’ll get there much sooner.”

Chris George, president and executive director of EVolve Houston.

“Houston is very important and significant because of our relation to the port. Whether it’s looking at hydrogen trucking for long haul trips or looking at reducing logistics cost for manufacturing and assembly, Houston has everything to offer.”

George continues.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston family's $20M donation drives neurodegeneration research

big impact

Neurodegeneration is one of the cruelest ways to age, but one Houston family is sharing its wealth to invigorate research with the goal of eradicating diseases like Alzheimer’s.

This month, Laurence Belfer announced that his family, led by oil tycoon Robert Belfer, had donated an additional $20 million to the Belfer Neurodegeneration Consortium, a multi-institutional initiative that targets the study and treatment of Alzheimer’s disease.

This latest sum brings the family’s donations to BNDC to $53.5 million over a little more than a decade. The Belfer family’s recent donation will be matched by institutional philanthropic efforts, meaning BNDC will actually be $40 million richer.

BNDC was formed in 2012 to help scientists gain stronger awareness of neurodegenerative disease biology and its potential treatments. It incorporates not only The University of Texas MD Anderson Cancer Center, but also Baylor College of Medicine, Massachusetts Institute of Technology (MIT) and Icahn School of Medicine at Mount Sinai.

It is the BNDC’s lofty objective to develop five new drugs for Alzheimer’s disease and related disorders over the next 10 years, with two treatments to demonstrate clinical efficacy.

“Our goal is ambitious, but having access to the vast clinical trial expertise at MD Anderson ensures our therapeutics can improve the lives of patients everywhere,” BNDC Executive Director Jim Ray says in a press release. “The key elements for success are in place: a powerful research model, a winning collaborative team and a robust translational pipeline, all in the right place at the right time.”

It may seem out of place that this research is happening at MD Anderson, but scientists are delving into the intersection between cancer and neurological disease through the hospital’s Cancer Neuroscience Program.

“Since the consortium was formed, we have made tremendous progress in our understanding of the molecular and genetic basis of neurodegenerative diseases and in translating those findings into effective targeted drugs and diagnostics for patients,” Ray continues. “Yet, we still have more work to do. Alzheimer's disease is already the most expensive disease in the United States. As our population continues to age, addressing quality-of-life issues and other challenges of treating and living with age-associated diseases must become a priority.”

And for the magnanimous Belfer family, it already is.

3 Houston innovators to know this week

who's who

Editor's note: Every week, I introduce you to a handful of Houston innovators to know recently making headlines with news of innovative technology, investment activity, and more. This week's batch includes a podcast with the founder of a new venture firm, a former astronaut and recent award recipient, and a health care innovator with fresh funding.

Zach Ellis, founder and managing partner of South Loop Ventures

Zach Ellis explains on the Houston Innovators Podcast that South Loop Ventures plans to invest in promising companies from across the country and bring them into Houston's ecosystem to grow and scale. Photo via LinkedIn

Houston has a lot of the right ingredients for commercialization and scaling up companies, so when Zach Ellis moved to town to stand up a venture capital firm that made investments in diverse founders, he decided to go about it in an innovative way.

South Loop Ventures, which Ellis launched two years ago, invests in pre-seed and seed-stage startups across health care, climatetech, aerospace, sports, and fintech. While the first handful of investments, which have already been made, are into Houston-based companies, Ellis explains on the Houston Innovators Podcast that the firm plans to invest in promising companies from across the country and bring them into Houston's ecosystem to grow and scale.

"Any investor wants to feel like they are looking at the best possible investment opportunities in which to deploy capital," Ellis says on the show. "So that's reason No. 1 to cast your net as widely as possible.

"At the same time, you want to give any investment that you make greatest chances of success," he continues. "The biggest factor of success outside of the team and the capital you give them, is the customers that they can call upon. In bringing targeted companies to Houston or connecting them with Houston, you introduce the opportunity for them to achieve rapid scale and work with world-class partners very efficiently." Read more.


Toby R. Hamilton, founder and CEO of Hamilton Health Box

Dr. Toby Hamilton has secured $10 million to grow his company. Photo via tmc.edu

A Houston company that is working on a value-based model for primary care has fresh funding to support its mission.

Hamilton Health Box announced the completion of a $10 million series A funding round led by 1588 Ventures with participation from Memorial Hermann Health System, Impact Ventures by Johnson & Johnson Foundation, Texas Medical Center Venture Fund, and the Sullivan Brothers.

The company, founded in 2019 by Dr. Toby R. Hamilton, will use the funding to fuel its expansion into rural areas to help assist those living in Health Professional Shortage Areas, or HPSAs. Read more.

Ellen Ochoa, former astronaut and center director at the NASA's Johnson Space Center

Ellen Ochoa was recognized for her leadership at NASA Johnson and for being the first Hispanic woman in space. Photo via NASA

Two astronauts recently received Presidential Medals of Freedom from President Joe Biden for their leadership in space.

Ellen Ochoa, the former center director and astronaut at the NASA's Johnson Space Center in Houston, and Jane Rigby, senior project scientist for NASA’s James Webb Space Telescope, were honored at the White House on May 3.

Ochoa spent 30 years with NASA, which included being the 11th director of JSC, deputy center director of JSC, and director of Flight Crew Operations. She served on the nine-day STS-56 mission aboard the space shuttle Discovery in 1993, and became the first Hispanic woman in space. She flew four more times to space with STS-66, STS-96, STS-110, and more.

“I’m so grateful for all my amazing NASA colleagues who shared my career journey with me,” Ochoa says in a NASA news release. Read more.

Houston health care institutions receive $22M to attract top recruits

coming to Hou

Houston’s Baylor College of Medicine has received a total of $12 million in grants from the Cancer Prevention & Research Institute of Texas to attract two prominent researchers.

The two grants, which are $6 million each, are earmarked for recruitment of Thomas Milner and Radek Skoda. The Cancer Prevention & Research Institute of Texas (CPRIT) announced the grants May 14.

Milner, an expert in photomedicine for surgery and diagnostics, is a professor of surgery and biomedical engineering at the Beckman Laser Institute & Medical Clinic at the University of California, Irvine and the university’s Chao Family Comprehensive Cancer Center

In 2013, Milner was named Inventor of the Year by the University of Texas at Austin. At the time, he was a professor of biomedical engineering at UT. One of his major achievements is co-development of the MasSpec Pen, a handheld device that identifies cancerous tissue within 10 seconds during surgical procedures.

Skoda is a professor of molecular medicine in the Department of Biomedicine at the University of Basel and the University Hospital Basel, both in Switzerland. He specializes in developing treatments for myeloproliferative neoplasms, which are a group of blood diseases including leukemia.

Other recruitment grants provided by the institute to Houston-area organizations are:

  • $4 million for recruitment of Susan Bullman to the University of Texas M.D. Anderson Cancer Center. She was an assistant professor at Seattle’s Fred Hutchinson Cancer Center, where she studied the connection between microbes and cancer.
  • $4 million for recruitment of Oren Rom to the University of Texas M.D. Anderson Cancer Center. Rom is an assistant professor of pathology and translational pathobiology at Louisiana State University Shreveport.
  • Nearly $2 million for recruitment of Lauren Hagler to conduct RNA cancer biology at Texas A&M University. She is a postdoctoral scholar in biochemistry at Stanford University.

The institute also awarded grants to five companies in the Houston area:

  • $4.7 million to 7 Hills Pharma for development of immunotherapies to treat cancer and prevent infectious diseases.
  • $4.5 million to Indapta Therapeutics for the Phase 1 trial of a cell therapy for treatment of multiple myeloma and non-Hodgkin’s lymphoma.
  • $2.75 million to Bectas Therapeutics for development of antibodies and biomarkers to overcome a type of resistance T-cell checkpoint therapy.
  • $2.69 million to MS Pen Technologies for development of technology that differentiates between normal tissue and cancerous tissue during surgery.
  • $2.58 million to Crossbridge Bio for development of an antibody-drug combination to treat certain solid tumors.